Quantification of CBFB-MYH11 fusion gene levels in paired peripheral blood and bone marrow samples by real-time PCR

被引:12
作者
Boeckx, N
De Roover, J
van der Velden, VHJ
Maertens, J
Uyttebroeck, A
Vandenberghe, P
van Dongen, JJM
机构
[1] Univ Hosp Gasthuisberg, Hematol Lab, Dept Lab Med, B-3000 Louvain, Belgium
[2] Univ Hosp Gasthuisberg, Ctr Mol Diagnost, B-3000 Louvain, Belgium
[3] Erasmus MC, Dept Immunol, Rotterdam, Netherlands
[4] Univ Hosp Gasthuisberg, Dept Internal Med, B-3000 Louvain, Belgium
[5] Univ Hosp Gasthuisberg, Dept Pediat, B-3000 Louvain, Belgium
[6] Univ Hosp Gasthuisberg, Dept Human Genet, B-3000 Louvain, Belgium
关键词
D O I
10.1038/sj.leu.2403961
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1988 / 1990
页数:3
相关论文
共 10 条
[1]   Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state [J].
Bounamici, S ;
Ottaviani, E ;
Testoni, N ;
Montefusco, V ;
Visani, G ;
Bonifazi, F ;
Amabile, M ;
Terragna, C ;
Ruggeri, D ;
Piccaluga, PP ;
Isidori, A ;
Malagola, M ;
Baccarani, M ;
Tura, S ;
Martinelli, G .
BLOOD, 2002, 99 (02) :443-449
[2]   Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].
Gabert, J ;
Beillard, E ;
van der Velden, VHJ ;
Bi, W ;
Grimwade, D ;
Pallisgaard, N ;
Barbany, G ;
Cazzaniga, G ;
Cayuela, JM ;
Cavé, H ;
Pane, F ;
Aerts, JLE ;
De Micheli, D ;
Thirion, X ;
Pradel, V ;
González, M ;
Viehmann, S ;
Malec, M ;
Saglio, G ;
van Dongen, JJM .
LEUKEMIA, 2003, 17 (12) :2318-2357
[3]   Quantitative real-time RT-PCR analysis of PML-RARα-mRNA in acute promyelocytic leukemia:: assessment of prognostic significance in adult patients from intergroup protocol 0129 [J].
Gallagher, RE ;
Yeap, BY ;
Bi, WL ;
Livak, KJ ;
Beaubier, N ;
Rao, S ;
Bloomfield, CD ;
Appelbaum, FR ;
Tallman, MS ;
Slack, JL ;
Willman, CL .
BLOOD, 2003, 101 (07) :2521-2528
[4]   GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].
KOLB, HJ ;
SCHATTENBERG, A ;
GOLDMAN, JM ;
HERTENSTEIN, B ;
JACOBSEN, N ;
ARCESE, W ;
LJUNGMAN, P ;
FERRANT, A ;
VERDONCK, L ;
NIEDERWIESER, D ;
VANRHEE, F ;
MITTERMUELLER, J ;
DEWITTE, T ;
HOLLER, E ;
ANSARI, H .
BLOOD, 1995, 86 (05) :2041-2050
[5]   Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21) [J].
Leroy, H ;
de Botton, S ;
Grardel-Duflos, N ;
Darre, S ;
Leleu, X ;
Roumier, C ;
Morschhauser, F ;
Lai, JL ;
Bauters, F ;
Fenaux, P ;
Preudhomme, C .
LEUKEMIA, 2005, 19 (03) :367-372
[6]   The importance of molecular monitoring in acute promyelocytic leukaemia [J].
Lo-Coco, F ;
Breccia, M ;
Diverio, D .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (03) :503-520
[7]  
Mrózek K, 2000, INT J HEMATOL, V72, P261
[8]   DETECTION OF THE CHROMOSOME-16 CBF-BETA-MYH11 FUSION TRANSCRIPT IN MYELOMONOCYTIC LEUKEMIAS [J].
POIREL, H ;
RADFORDWEISS, I ;
RACK, K ;
TROUSSARD, X ;
VEIL, A ;
VALENSI, F ;
PICARD, F ;
GUESNU, M ;
LEBOEUF, D ;
MELLE, J ;
DREYFUS, F ;
FLANDRIN, G ;
MACINTYRE, E .
BLOOD, 1995, 85 (05) :1313-1322
[9]   New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFB-MYH11+ acute myeloid leukemia based on quantification of fusion transcripts [J].
Schnittger, S ;
Weisser, M ;
Schoch, C ;
Hiddemann, W ;
Haferlach, T ;
Kern, W .
BLOOD, 2003, 102 (08) :2746-2755
[10]   Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse [J].
Tobal, K ;
Newton, J ;
Macheta, M ;
Chang, J ;
Morgenstern, G ;
Evans, PAS ;
Morgan, G ;
Lucas, GS ;
Yin, JAL .
BLOOD, 2000, 95 (03) :815-819